All patients list_Shirotake et al_Molecular and Clinical Oncology 2018.xlsx

A list of the clinical and pathological data of 209 patients with advanced renal cell carcinoma (with or without metastasis) treated with molecular targeted therapy between April 25, 2008 and February 27, 2017 in Saitama Medical University International Medical Center. These patients in this list were automatically isolated from electronic medical records using the terms “sorafenib”, “sunitinib”, “axitinib”, “pazopanib”, “temsirolimus”, “everolimus”, “renal tumor”, and “renal cell carcinoma”. The analyses of this data is published in Molecular and Clinical Oncology.